Patient & Visitor Alert: Because flu cases are on the rise, starting February 24, children 12 and younger
will be restricted from visiting hospitals and certain inpatient facilities throughout Carolinas HealthCare System. Learn more.


Carolinas HealthCare System

Research and Clinical Trials

Title  
Gilead 1490
Brief Description  
This is a study for treatment-naïve HIV patients. This study is comparing the safety and efficacy of a new drug combination (GS-9883/FTC/TAF) to Dolutegravir + FTC/TAF. The trial is expected to last 2 years. The study sponsor will cover all cost related to the study including office visits, labs and medications.
Who may be Eligible  
Patients may be eligible if they meet the following: Adults (18 years or older); HIV positive with no history of therapy; Normal maintenance labs and EKG; Agree to not become pregnant or father a child during the study; Agree to birth control methods as outlined by the study protocol; have no new infections in the past month that required hospitalization or IV therapy; No history of cancer in the past 5 years; New acute hepatitis B is an exclusion; Active tuberculosis is an exclusion.
Start Date  
01/31/2016
IRB Number  
02-16-04A
Principal Investigator  
Johnson, Marc
Contact Name  
Jessica

For More Information, Contact   Jessica  A.  Kearney-Bryan , BSN
Phone:  (704) 355-0244  Fax:  (704) 446-7641 
Email:  Jessica.Kearney-Bryan@carolinashealthcare.org
Address:  1350 S. Kings Drive, 3rd Floor Myer's Park ID Clinic
Charlotte, NC 28207
Close